Lifetime costs and health gain of the current practice for CVD prevention and of the most cost-effective package of interventions under different discounting and costing assumptions.

*Cost-effective package includes population-wide mandatory limits on salt in breads, margarines and cereals, and a mix of diuretic, calcium channel blocker and ACE inhibitor drugs for everyone with at least 5% risk of a CVD event in the next five years.
**Statins provided for everyone with at least 5% risk of a CVD event in the next five years, at an annual cost of $18.25 (equivalent to the current price in New Zealand).